These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 10623718

  • 21. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 22. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
    Kobylarz J, Piwowarczyk A, Romanowska-Dixon B, Balwierz W, Dłuzniewska A.
    Klin Oczna; 2006 Oct; 108(1-3):55-9. PubMed ID: 16883942
    [Abstract] [Full Text] [Related]

  • 23. Tailoring treatment for retinoblastoma.
    Arch Dis Child; 2002 May; 86(5):373. PubMed ID: 11970937
    [No Abstract] [Full Text] [Related]

  • 24. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding.
    Sun YB, Hui P, Punyara K, Bi MC, Li SH, Teng SY, Song E.
    Chin Med J (Engl); 2013 May; 126(8):1587. PubMed ID: 23595400
    [No Abstract] [Full Text] [Related]

  • 25. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [Abstract] [Full Text] [Related]

  • 26. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.
    Kim JW.
    Int Ophthalmol Clin; 2015 Dec; 55(1):77-96. PubMed ID: 25436495
    [No Abstract] [Full Text] [Related]

  • 27. What is the best treatment for retinoblastoma?
    Harbour JW.
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract] [Full Text] [Related]

  • 28. Retinoblastoma: evidence for stage-based chemotherapy.
    Chung CY, Medina CA, Aziz HA, Singh AD.
    Int Ophthalmol Clin; 2015 Sep; 55(1):63-75. PubMed ID: 25436494
    [No Abstract] [Full Text] [Related]

  • 29. Retinocytoma shows lack of response to chemoreduction.
    Chung J, Turaka K, Shields CL.
    J Pediatr Ophthalmol Strabismus; 2010 Dec 22; 47 Online():e1-3. PubMed ID: 21175116
    [Abstract] [Full Text] [Related]

  • 30. Trilateral retinoblastoma: is the location of the intracranial tumor important?
    Moll AC, Imhof SM, Schouten-Van Meeteren AY, Boers M.
    Cancer; 2000 Feb 15; 88(4):965-7. PubMed ID: 10679669
    [No Abstract] [Full Text] [Related]

  • 31. Chemosurgery for retinoblastoma: what we know after 5 years.
    Abramson DH.
    Arch Ophthalmol; 2011 Nov 15; 129(11):1492-4. PubMed ID: 22084221
    [No Abstract] [Full Text] [Related]

  • 32. Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.
    Francis JH, Marr BP, Brodie SE, Gobin YP, Abramson DH.
    JAMA Ophthalmol; 2014 Aug 15; 132(8):1024-5. PubMed ID: 25124953
    [No Abstract] [Full Text] [Related]

  • 33. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
    Vajzovic LM, Murray TG, Aziz-Sultan MA, Schefler AC, Fernandes CE, Wolfe SC, Hess DJ, Dubovy SR.
    Arch Ophthalmol; 2010 Dec 15; 128(12):1619-23. PubMed ID: 21149791
    [No Abstract] [Full Text] [Related]

  • 34. Choroidal Invasion in Retinoblastoma Treated with Intrarterial Chemotherapy.
    Abramson DH, Francis JH, Gobin YP.
    Ophthalmol Retina; 2018 Jan 15; 2(1):9. PubMed ID: 31047314
    [No Abstract] [Full Text] [Related]

  • 35. Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma.
    Narang S, Mashayekhi A, Rudich D, Shields CL.
    Clin Exp Ophthalmol; 2012 Jan 15; 40(7):736-42. PubMed ID: 22300311
    [Abstract] [Full Text] [Related]

  • 36. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
    Rojanaporn D, Kaliki S, Bianciotto CG, Iturralde JC, Say EA, Shields CL.
    Arch Ophthalmol; 2012 May 15; 130(5):585-90. PubMed ID: 22652844
    [Abstract] [Full Text] [Related]

  • 37. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H, Khetan V, Halliday W, Héon E, Chan HS, Gallie BL.
    Arch Ophthalmol; 2009 Aug 15; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract] [Full Text] [Related]

  • 38. Successful treatment of early detected trilateral retinoblastoma using standard infant brain tumor therapy.
    Wright KD, Qaddoumi I, Patay Z, Gajjar A, Wilson MW, Rodriguez-Galindo C.
    Pediatr Blood Cancer; 2010 Sep 15; 55(3):570-2. PubMed ID: 20658634
    [Abstract] [Full Text] [Related]

  • 39. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
    Padrón-Pérez N, Català-Mora J.
    J Fr Ophtalmol; 2014 Feb 15; 37(2):176. PubMed ID: 24210940
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J, Xue K, Gao YJ, Yuan YF, Shan HD, Bi YW.
    Zhonghua Yan Ke Za Zhi; 2010 Apr 15; 46(4):312-6. PubMed ID: 20654057
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.